BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38436871)

  • 1. Stage-by-stage analysis of the effect of blood transfusion on survival after curative hepatectomy for hepatocellular carcinoma-a retrospective study.
    She WH; Tsang SHY; Dai WC; Chan ACY; Lo CM; Cheung TT
    Langenbecks Arch Surg; 2024 Mar; 409(1):83. PubMed ID: 38436871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis.
    Peng T; Zhao G; Wang L; Wu J; Cui H; Liang Y; Zhou R; Liu Z; Wang Q
    Clin Transl Oncol; 2018 Jun; 20(6):719-728. PubMed ID: 29080121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.
    Wada H; Eguchi H; Nagano H; Kubo S; Nakai T; Kaibori M; Hayashi M; Takemura S; Tanaka S; Nakata Y; Matsui K; Ishizaki M; Hirokawa F; Komeda K; Uchiyama K; Kon M; Doki Y; Mori M
    Surg Today; 2018 Jan; 48(1):73-79. PubMed ID: 28597349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of hepatocellular carcinoma resection with postoperative complications - a propensity-score-matched analysis.
    Chok KSH; Chan MMY; Dai WC; Chan ACY; Cheung TT; Wong TCL; She WH; Lo CM
    Medicine (Baltimore); 2017 Mar; 96(12):e6430. PubMed ID: 28328851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of perioperative transfusion of blood components on the long-term prognosis of hepatocellular carcinoma].
    Peng T; Wang LM; Wu JX; Liu M; Li XY; Rong WQ; Wu F; Zhao WQ; Zhao GH
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(14):1079-1083. PubMed ID: 28395433
    [No Abstract]   [Full Text] [Related]  

  • 6. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma.
    Hanazaki K; Kajikawa S; Shimozawa N; Matsushita A; Machida T; Shimada K; Yazawa K; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2005; 52(62):524-9. PubMed ID: 15816471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.
    Peng T; Wang L; Cui H; Li X; Liu M; Yu J; Wu J; Zhao G; Liu Z
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):620-627. PubMed ID: 32988700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraoperative blood transfusion does not impact overall and recurrence-free survival after curative hepatectomy for hepatocellular carcinoma: A propensity-score-matched and inverse probability of treatment-weighted study.
    Tan LLY; Chew VTW; Syn N; Tan EK; Koh YX; Teo JY; Cheow PC; Jeyaraj PR; Chow PKH; Chan CY; Chung AYF; Ooi LLPJ; Goh BKP
    J Surg Oncol; 2023 Mar; 127(4):598-606. PubMed ID: 36354172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
    Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
    J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis.
    Nakayama H; Okamura Y; Higaki T; Moriguchi M; Takayama T
    J Gastroenterol; 2023 Feb; 58(2):171-181. PubMed ID: 36592217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
    Yamashita YI; Hayashi H; Imai K; Okabe H; Nakagawa S; Kitamura F; Uemura N; Nakao Y; Yusa T; Itoyama R; Yamao T; Umesaki N; Miyata T; Chikamoto A; Shimokawa M; Baba H
    World J Surg; 2019 Nov; 43(11):2894-2901. PubMed ID: 31312946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy.
    Kuroda S; Tashiro H; Kobayashi T; Oshita A; Amano H; Ohdan H
    World J Surg; 2012 Mar; 36(3):651-8. PubMed ID: 22270991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intraoperative blood transfusion on long-term outcomes of liver transplantation for hepatocellular carcinoma.
    Dai WC; Chok KSH; Sin SL; Chan ACY; Cheung TT; Wong TCL; Lo CM
    ANZ J Surg; 2018 May; 88(5):E418-E423. PubMed ID: 27806436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis.
    Xu HW; Liu F; Li HY; Wei YG; Li B
    Surg Endosc; 2018 Feb; 32(2):712-719. PubMed ID: 28726140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study.
    Sugita S; Sasaki A; Iwaki K; Uchida H; Kai S; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2008 Mar; 34(3):339-45. PubMed ID: 17400417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Allogeneic Blood Transfusion in Hepatic Resection.
    Inoue Y; Ishii M; Fujii K; Kitada K; Kuramoto T; Takano Y; Matsuo K; Tomioka A; Yamaguchi T; Yokohama K; Ohama H; Harada S; Osumi W; Tsuchimoto Y; Terazawa T; Ogura T; Masubuchi S; Yamamoto M; Imoto A; Asai A; Shirai Y; Inoue M; Fukunishi S; Goto M; Higuchi K; Uchiyama K
    Am Surg; 2021 Feb; 87(2):228-234. PubMed ID: 32927956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 20. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma.
    Asahara T; Katayama K; Itamoto T; Yano M; Hino H; Okamoto Y; Nakahara H; Dohi K; Moriwaki K; Yuge O
    World J Surg; 1999 Jul; 23(7):676-80. PubMed ID: 10390585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.